Skip to main content
. 2023 Feb 14;11(2):e00253-23. doi: 10.1128/spectrum.00253-23

TABLE 3.

Oligonucleotide primers used in this study

Name Sequence in 5′ to 3′ directiona
5′GFP-XhoI AGCTctcgagATGAGTAAGGGAGAAGAACTTTTCACTGGA
3'GFP-EcoRV AGCTgatatcTTATTTGTATAGTTCATCCATGCCATGTGT
5′CaACT1term-EcoRI AGCTgaattcGAGTGAAATTCTGGAAATCTGGAAATCT
3'CaACT1term-SpeI AGCTactagtTAGATTATGGTCGACATTTTATGATGGAAT
5′NEUfwd-ApaI ACTGgggcccGTAATTGTAGTAAGAATGACAAGTATCAG
5'NEUrev-ANP-XhoI ACTGctcgagttaattaaggcgccggcgcgccGGAAGGACGATGAAGGAGAGAAAG
3′NEUfwd-SacII ACTGccgcggTAAACAAGTGGTATTCAAGCACAATTC
3'NEUT5L-SacIPacI GCTGgagctcttaattaaTAACCCACTGAATTCTACATCGAAC
3'ECE1prom-XhoI TCATctcgagTTTAACGAATGGAAAATAGTTGGTAGTAAAATAAAGG
5′ECE1prom500-AscI TTCCggcgcgccGTCATTTGTAGGATTTTCAGCAGAACA
5′ECE1prom1000-AscI TTCCggcgcgccAGCGAAACATTTTTTTTTTTCAACGGCTC
5′ECE1prom1500-AscI TTCCggcgcgccACCCTAGTAATTATATGAAACATGCCCA
5′ECE1prom2000-AscI TTCCggcgcgccAACATTAACGACGCAAAATACAAACTTGGT
5′ECE1prom2500-AscI TTCCggcgcgccGTAAGCATTTTGGAGTAATACCATAGTTG
5′ECE1prom3000-AscI TTCCggcgcgccGCAAATAGAATTGTTCTATTGCTTAGCTTTAG
R1-CaACT1 TCAGACCAGCTGATTTAGGTTTG
R2-CaACT1 GTGAACAATGGATGGACCAG
R1-CaECE1 ATCGAAAATGCCAAGAGAG
R2-CaECE1 AGCATTTTCAATACCGACAG
R1-CaGFP CTGAAGTCAAGTTTGAAGGTGATAC
R2-CaGFP GCAGATTGTGTGGACAAGTAATG
GFP veri rev TGATCTGGGTATCTCGCAAAGCAT
a

Lowercase: restriction sites.